Hyogo Prefectural Amagasaki General Medical Center

Amagasaki, Hyōgo 660-8550

0 studies enrolling now · 9 studies all time

What they study most

Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer, Atrial Fibrillation, Heart Failure, Macular Edema Secondary to Retinal Vein Occlusion, Neovascular Age-Related Macular Degeneration, Prevention of Stroke or Systemic Embolism, Respiratory Tract Infection, Venous Thromboembolism

Studies at this site

• Computerized Registry of Patients With Venous Thromboembolism (RIETE) — Recruiting now
• A Study to Learn How Well a Higher Amount of Aflibercept Given as an Injection Into the Eye Works and How Safe it is in People With Reduced Vision Due to Swelling in the Macula, Central Part of the Retina Caused by a Blocked Vein in the Retina (Macula Edema Secondary to Retinal Vein Occlusion) — Completed
• A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer — Running, not enrolling
• A Study of Ponsegromab in People With Heart Failure — Stopped early
• Study of the Effects of High Dose Aflibercept Injected Into the Eye of Patients With an Age-related Disorder That Causes Loss of Vision Due to Growth of Abnormal Blood Vessels at the Back of the Eye — Completed
• A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy. — Completed
• A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early
• A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Preserved Ejection Fraction — Completed
• A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Reduced Ejection Fraction — Completed